Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

June 2017

Name: Tumor Board: Advances in Managing EGFR-Mutant NSCLC: Applying Evidence Across the Disease Continuum
Start: 2025-09-07T18:30:00+02:00
End: 2025-09-07T19:30:00+02:00

June 1, 2017

Deb Violette, Lung Cancer Survivor and Advocate: Her Story

By

Patient Advocacy & Survivorship

Posted: June 2017 Editor’s note: IASLC Lung Cancer News is committed to including the patient’s voice and experience of having lung cancer as part of our editorial breadth and mission. […]
June 1, 2017

Dziadziuszko Follows in Footsteps of Thoracic Oncology Icon, Receives Award in Heine Hansen’s Name

By

Uncategorized

Posted: June 2017 By Keightley Amen, BA, ELS In 2015, the International Association for the Study of Lung Cancer (IASLC) and the European Society for Medical Oncology (ESMO) established an […]

June 2017

Deb Violette, Lung Cancer Survivor and Advocate: Her Story

Dziadziuszko Follows in Footsteps of Thoracic Oncology Icon, Receives Award in Heine Hansen’s Name

IS03: Satellite EBAC/CME Symposium by Answers in CME: Reshaping the Management of Metastatic NSCLC: Tackling HER2 Overexpression to Elevate Outcomes

Tumor Board: Advances in Managing EGFR-Mutant NSCLC: Applying Evidence Across the Disease Continuum

COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC